| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.343 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 5.343 | 14.474 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 6.738 | 13.624 | 13.359 | 10 | 0 | 0 | 9 | 10 | 0 | 10 |
| Gross Profit/Loss - EUR | -1.396 | 850 | -13.359 | -10 | 0 | 0 | -9 | -10 | 0 | -10 |
| Net Profit/Loss - EUR | -1.396 | 850 | -13.359 | -10 | 0 | 0 | -9 | -10 | 0 | -10 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biopanis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 5.042 | 20.346 | 21.290 | 20.891 | 20.487 | 20.098 | 19.654 | 19.705 | 19.645 | 19.545 |
| Inventories | 0 | 14.474 | 14.274 | 14.012 | 13.740 | 13.480 | 13.181 | 13.222 | 13.182 | 13.108 |
| Receivables | 4.821 | 5.819 | 6.939 | 6.812 | 6.680 | 6.554 | 6.408 | 6.428 | 6.409 | 6.373 |
| Cash | 220 | 52 | 77 | 68 | 66 | 65 | 65 | 55 | 55 | 64 |
| Shareholders Funds | -55.402 | -53.987 | -66.432 | -65.223 | -63.960 | -62.747 | -61.365 | -61.565 | -61.379 | -61.046 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 60.444 | 74.332 | 87.722 | 86.114 | 84.446 | 82.846 | 81.018 | 81.270 | 81.023 | 80.591 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1071 - 1071" | |||||||||
| CAEN Financial Year |
1071
|
|||||||||
Comments - Biopanis Srl